Here, we investigated the potential in vivo protective effects of the two rA1M-variants in a mild variant of the glycerol-induced rhabdomyolysis mouse model where AKI develops as a result of muscle rupture with release of myoglobin, heme, radicals, and other tissue components. Here, MB is linked to rhabdomyolysis.